Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin.
about
Antibiotic use and misuse during pregnancy and delivery: benefits and risksA Model for Group B Streptococcus Pilus Type 1: The Structure of a 35-kDa C-Terminal Fragment of the Major Pilin GBS80The Crystal Structure Analysis of Group B Streptococcus Sortase C1: A Model for the “Lid” Movement upon Substrate BindingStructure ofStreptococcus agalactiaetip pilin GBS104: a model for GBS pili assembly and host interactionsUnderstanding the regulation of Group B Streptococcal virulence factorsFluoroquinolone-resistant Streptococcus agalactiae: epidemiology and mechanism of resistance.Multicenter study of the mechanisms of resistance and clonal relationships of Streptococcus agalactiae isolates resistant to macrolides, lincosamides, and ketolides in Spain.Preliminary crystallographic study of the Streptococcus agalactiae sortases, sortase A and sortase C1.Patterns of antibiotic resistance among group B streptococcus isolates: 2001-2004.Emergence of the first levofloxacin-resistant strains of Streptococcus agalactiae isolated in Italy.High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York hospitalAntibiotic resistance of Streptococcus agalactiae isolated from pregnant women in Garankuwa, South Africa.Rapid determination of macrolide and lincosamide resistance in group B streptococcus isolated from vaginal-rectal swabs.Culture and Real-Time PCR Based Maternal Screening and Antibiotic Susceptibility for Group B Streptococcus: An Iranian ExperienceUpdate on clindamycin in the management of bacterial, fungal and protozoal infections.Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.Epidemiology of Invasive Group B Streptococcal Disease in Alberta, Canada, from 2003 to 2013Integrated network-diversity analyses suggest suppressive effect of Hodgkin's lymphoma and slightly relieving effect of chemotherapy on human milk microbiome.Comparison of various culture methods for isolation of group B streptococcus from intrapartum vaginal colonizationAntibiotic susceptibility patterns and prevalence of group B Streptococcus isolated from pregnant women in Misiones, Argentina.Survey of strain distribution and antibiotic resistance pattern of group B streptococci (Streptococcus agalactiae) isolated from clinical specimens.Molecular-based screening for perinatal group B streptococcal infection: implications for prevention and therapy.Antimicrobial susceptibilities of group B streptococcus isolates from prenatal screening samples.Characterization of clinical blood isolates of Streptococcus agalactiae with reduced susceptibility to levofloxacin.Antimicrobial susceptibility of group B streptococci collected in two Belgian hospitals.Antibiotic resistance and penicillin tolerance in ano-vaginal group B streptococci.Activity of iclaprim against clinical isolates of Streptococcus pyogenes and Streptococcus agalactiae.Late Onset Streptococcus agalactiae Meningitis following Early Onset Septicemia: A Preventable Disease?Synergistic effect between two bacteriocin-like inhibitory substances produced by Lactobacilli Strains with inhibitory activity for Streptococcus agalactiae.Analysis of phenotype, genotype and serotype distribution in erythromycin-resistant group B streptococci isolated from vaginal flora in Southern Ireland
P2860
Q27003944-5BF23ADF-C2A6-413E-86DF-E9C244CE15D3Q27667003-EB419A09-3D1B-47B2-9A4A-417F4B0F24A7Q27675265-CC603F82-81FA-4A84-9F29-B9FEF589DE65Q27678225-67B26750-6E63-43D7-A770-4376A82CA70CQ28237019-05418497-F126-4A3A-8398-96939C5C53C6Q33836671-7A183F21-2F86-4014-95B3-F2E8B23789EAQ33836754-2BF832AB-D670-4D61-AD1C-5DBD23101FCFQ34109625-D58CA8F5-DCA5-49CD-93F3-0C65E9E8B044Q35056789-D5C86EEE-C39F-4AFC-8110-175AE5F27A1FQ35168877-AA4EA0CB-A354-470C-8725-EB9A4BEEFEDBQ35689360-CF2549FF-4FB0-4749-90B1-C5FCEA71F91AQ35750604-EF062597-2CCF-4834-9031-7A0CE09C1EE8Q35925097-B05B710E-AAB9-4235-BBE6-75C61CEF0250Q36718067-FFB81565-C312-4AA3-8CBE-3E898423BDA7Q36967293-2DBA142A-BC0C-4C43-9036-8E078FC399C5Q36993479-6586D490-FE8E-46ED-9A86-61B9D87A82D6Q37040500-06114444-4D65-4C06-8751-9CA98D69CB0FQ37076557-446E9F19-468D-475E-9B8B-A4A850615B03Q37136012-CFFE6CD5-5700-45E3-8914-3E43D50CCD8FQ37159137-E02271C4-E188-4975-823E-BB37FC2E2774Q37254222-6BEA275B-BC1C-426C-AFC8-D5780659AE2CQ38119909-89A9B6E8-995D-40D4-9A46-272DD2D1C212Q43125901-E15938A5-16D0-4D08-93CE-15FB552A70BBQ43623292-8AC2403A-460B-4704-A160-95DFD972C6D4Q44915009-6F8AB44D-BB8F-4FED-B8A9-0AFE71B8C2F4Q46104075-483F07AB-39A4-4150-AB37-CF498FB90CD6Q46211943-F76827F6-7360-4444-B614-854EA6B68A72Q47134871-4260C6C1-41BE-45EC-A417-D0D446B1D35CQ48053096-A89B733C-CBEB-4D3E-B680-601A6CB0724BQ58359204-2AD7EB09-6D5C-4EC5-A296-2C6947708955
P2860
Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Resistance of group B streptoc ...... erythromycin and clindamycin.
@ast
Resistance of group B streptoc ...... erythromycin and clindamycin.
@en
type
label
Resistance of group B streptoc ...... erythromycin and clindamycin.
@ast
Resistance of group B streptoc ...... erythromycin and clindamycin.
@en
prefLabel
Resistance of group B streptoc ...... erythromycin and clindamycin.
@ast
Resistance of group B streptoc ...... erythromycin and clindamycin.
@en
P2093
P2860
P1476
Resistance of group B streptoc ...... erythromycin and clindamycin.
@en
P2093
Alexander J McAdam
Judith S Heelan
Meredith E Hasenbein
P2860
P304
P356
10.1128/JCM.42.3.1263-1264.2004
P407
P577
2004-03-01T00:00:00Z